Dr. Behl is a research physician at Sutter Institute for Medical Research (SIMR). Her research interests include Oncology research focusing on lung cancer.

Meet Deepti Behl

Breast Cancer Research

Search

Clinical Trials

Adjuvant (Alliance A191901)

Adjuvant (NRG BR007)

Adjuvant Breast (EndoPredict Extended Endocrine Trial EXET Myriad)

Adjuvant (Alliance A011801 Compass HER2 Residual Disease)

City of Hope 96144 Molecular Genetics Studies of Cancer Patients and Their Relatives

Publications

Higher absolute lymphocyte counts predict lower mortality from early-stage triple-negative breast cancer.

Engaging patients in decisions about cancer screening: exploring the decision journey through the use of a patient portal.

Breast cancer chemoprevention in primary care - assessing readiness for change.

Adiposity, inflammation, genetic variants and risk of post-menopausal breast cancer findings from a prospective-specimen-collection, retrospective-blinded-evaluation (PRoBE) design approach.

Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?

Research Studies

Impact of COVID-19 on Cancer Care Management

Breast Cancer Chemoprevention in Primary Care at Geisinger

Featured Investigator

Deepti Behl

About Sutter

Find Care

Featured Services

Patient Resources

Our Team